|
Topic Name: Medicine and biology take a lesson in physics
Category: Biomedical
Research persons: Dr Paul Ginsparg
Location: Cornell University, Ithaca, NY, United States
Details
Dr Paul Ginsparg, one of the key instigators of the world's first free-access
electronic archive for
physics research,
will join leading players from the biomedical
community at a conference in New York next month to discuss how free-access
to biomedical research on the internet will change the way that biomedical
science is used, communicated and done.
The conference will be opened by
Dr Harold
Varmus, the former head of the US National Institutes for Health who last
year proposed the creation of PubMed Central, an archive for research published
in the biomedical sciences. "Electronic communication is making dramatic changes
in the way information is exchanged among scientists," says Dr Varmus, "Within
biomedicine the full potential of electronic communication has yet to be
realized."
The recently launched PubMed Central archive,
http://pubmedcentral.nih.gov,together
with other open-access publishing initiatives promise to transform the
biomedical landscape by making research available for free to all. However, even
PubMed Central only goes part of the way to catching up with the physics
publishing model where research is submitted to the open-access archive before
peer-review and publication to encourage rapid distribution of research results.
For biomedicine, where the peer-review issue is much more sensitive, PubMed
Central will only archive articles that have been peer-reviewed.
"It is thrilling that the biomedical community is beginning to join the
1990s," says
Dr
Ginsparg, whose pre-print archive of physics research,
http://arXiv.org, was launched in 1991 at the Los
Alamos National Laboratory archive. Today the physics e-Print archive regularly
processes between 1000 and 2000 electronic transactions per hour and has
revolutionised the way physicists communicate research findings by allowing them
to distribute articles rapidly, efficiently and before they are printed by a
commercial publisher.
Open access publishing in biomedicine could also change the way science
impacts on the general public who regularly interface with the produce of
medical research in hospitals or when visiting their doctor or pharmacist.
Jean Hoffman-Anuta,
herself a clinical pharmacist, will discuss the issue of accessing research
information in the light of her own experience as a member of the general public
who turned to the latest medical research papers in order to receive the best
medical treatment. The conference will also include sessions on the changing
nature of publishing and librarianship and the technology shaping the
open-access publishing initiatives of the future.
The conference, organized by BioMed
Central, will be held on the 6-7 July 2000 at the
New York Academy of Medicine, New York, USA.
There are a limited number of places available to the media who are welcome
to attend this event free of charge. To register or receive further information
please contact Andrew McLaughlin, or alternatively visit
http://www.biomedcentral.com/conference.asp to register.
Relate Some Notes
1. Conference organizing committee: Professor Pat Brown (Associate Professor of
Biochemistry at Stanford University), Dr Fiona Godlee (Editorial Director
(Medicine), BioMed Central) Dr David Lipman (Director of the National Center for
Biotechnology at the NIH) and Jan Velterop (Publishing Director of Nature).
2. Dr Harold Varmus's proposal for an archive of electronic publications in the
biomedical sciences can be found at:
http://www.nih.gov/about/director/pubmedcentral/ebiomedarch.htm
3. PubMed Central:
http://www.pubmedcentral.nih.gov
4. The physics e-Print archive:
http://xxx.lanl.gov
5. Registration to attend the conference will be free to journalists. A fee of
$250 (US) for individuals from not-for-profit organizations and $750 (US) to
individuals from corporate organizations will be applicable.
6. Directions to the New York Academy of Medicine can be found at
http://www.nyam.org/nyam/info.html
7. BioMed Central is a new publishing house that will give free access to
research at http://www.biomedcentral.com.
BioMed Central is part of the Current Science Group -- a group of independent
companies that collaborate closely with each other to publish and develop
information and services for the professional biomedical community. The Group
has its head-office in London (UK), with additional offices in Philadelphia, New
York and Tokyo.
http://www.current-science-group.com
8. Recent articles on BioMed Central can be found at:
http://www.nature.com/cgi-taf/DynaPage.taf
http://www.thelancet.com/newlancet/sub/issues/vol355no9220/menu_NOD999.html
http://www.economist.com/contentframeset.cgi (subscriptions required)
About Researcher :
Dr Paul Ginsparg
Professor
Cornell University
Ithaca, NY
E-mail: ginsparg@cornell.edu
Related Online Resource:
The
Biology Project: Biochemistry,
Biomedical
engineering
Department of Biochemistry, University of
Oxford
| Related research: |
BEST WAY TO DETECT AIRBORNE PATHOGENS, Bone graft alternative, Radiation Therapy for Cancer Patients Controlled & Could Speed Up by Machine Learning, 21st-century pack mule: MIT's 'exoskeleton' lightens the load, 3D Ultrasound brain scanner : successfully image the brain, 450 new terms for describing gene products involved in microbe-host interactions., A signaling pathway crucially involved in Crohn's disease and Ulcerative Colitis, Bath Pain Management Unit has developed an observational tool, Biomolecular World : connections among biology and physics, and molecules and computers, Cloning from Adult DNA, Compute-intensive applications : The new Cell Accelerator Board, Developed simple bladder cancer test, Duke scientists map imprinted genes in human genome, say a modern-day Rosetta stone, Emotions play a part in moral judgments, Factors of Prostate Cancer Risk, Firsts with Bursts of Light ,Team generates most energetic terahertz pulses yet, observes useful optical phenomena, Fluorescence microscopy : medical, commercial applications, Herceptin to treat HER2-positive breast cancer by destroing the cancer stem cells., Hopkins research shows survival of newborns with abdominal holes differs according to hospital, Hopkins study shows Vaginal reconstruction not needed for most inter-sex females, Human Virus may Prove useful in Attacking the Deadliest form of Brain Tumors, Jefferson researchers find anti-inflammation molecule helps fight MS-like disease, MIT radar technology fights breast cancer using microwave heat treatments, Molecular devices’ remarkably precise scans of cellular activity could revolutionize medicine, Nanoscale Droplets for drug delivery and anticancer applications
|
|
